Lupine: January 5, 2023 Lupine launches new fixed-dose three-drug combination DIFIZMA® DPI for the treatment of inadequately controlled asthma
Mumbai, January 05, 2023: Global pharmaceutical company Lupine Limited (Lupin) today announced the launch of a new fixed-dose three-drug combination (FDC) of indacaterol, glycopyrronium and...